Journal of Clinical Oncology, Vol 2, 472-483, Copyright © 1984 by American Society of Clinical Oncology

ARTICLES

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation

H Schipper, J Clinch, A McMurray and M Levitt

The classical criteria for the evaluation of clinical trials in cancer reflect alterations in physical well-being, but are insensitive to other important factors, such as psychosocial state, sociability, and somatic sensation that may play a critical role in determining the patients' functional response to their illness and its treatment. The Functional Living Index-Cancer is designed for easy, repeated patient self-administration. It is a 22-item questionnaire that has been validated on 837 patients in two cities over a three-year period. Criteria for validity include stability of factor analysis, concurrent validation studies against the Karnofsky, Beck Depression, Spielberger State and Trait Anxiety, and Katz Activities of Daily Living scales, as well as the scaled version of The General Health Questionnaire and The McGill/ Melzack Pain Index. The index is uncontaminated by social desirability issues. The validation studies demonstrate the lack of correlation between traditional measures of patient response and other significant functional factors such as depression and anxiety (r = 0.33), sociability and family interaction, and nausea. These findings elucidate the frequently observed discrepancies between traditional assessments of clinical response and overall functional patient outcome. The index is proposed as an adjunct to clinical trials assessment and may provide additional patient functional information on which to analyse the outcome of clinical trials or offer specific advice to individual patients.

This article has been cited by other articles:

				C. Wan, Q. Meng, Z. Yang, X. Tu, C. Feng, X. Tang, and C. Zhang Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer Ann. Onc., July 24, 2008; (2008) mdn417v1. [Abstract] [Full Text] [PDF]

				C. Zimmermann, R. Riechelmann, M. Krzyzanowska, G. Rodin, and I. Tannock Effectiveness of Specialized Palliative Care: A Systematic Review JAMA, April 9, 2008; 299(14): 1698 - 1709. [Abstract] [Full Text] [PDF]

				C. M. Moinpour, A. M. Denicoff, D. W. Bruner, A. B. Kornblith, S. R. Land, A. O'Mara, and E. Trimble Funding Patient-Reported Outcomes in Cancer Clinical Trials J. Clin. Oncol., November 10, 2007; 25(32): 5100 - 5105. [Abstract] [Full Text] [PDF]

				D. W. Bruner Outcomes Research in Cancer Symptom Management Trials: The Radiation Therapy Oncology Group (RTOG) Conceptual Model J Natl Cancer Inst Monographs, October 1, 2007; 2007(37): 12 - 15. [Abstract] [Full Text] [PDF]

				E. J. Pearson, J. G Todd, and J. M Futcher How can occupational therapists measure outcomes in palliative care? Palliative Medicine, September 1, 2007; 21(6): 477 - 485. [Abstract] [PDF]

				C. Saxby, R. Ackroyd, S. Callin, C. Mayland, and S. Kite How should we measure emesis in palliative care? Palliative Medicine, July 1, 2007; 21(5): 369 - 383. [Abstract] [PDF]

				K. A. O'Connell and S. M. Skevington To measure or not to measure? Reviewing the assessment of spirituality and religion in health-related quality of life Chronic Illness, March 1, 2007; 3(1): 77 - 87. [Abstract] [PDF]

				S. Kudoh, K. Takeda, K. Nakagawa, M. Takada, N. Katakami, K. Matsui, T. Shinkai, T. Sawa, I. Goto, H. Semba, et al. Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904) J. Clin. Oncol., August 1, 2006; 24(22): 3657 - 3663. [Abstract] [Full Text] [PDF]

				J. Kirkova, M. P. Davis, D. Walsh, E. Tiernan, N. O'Leary, S. B. LeGrand, R. L. Lagman, and K. M. Russell Cancer Symptom Assessment Instruments: A Systematic Review J. Clin. Oncol., March 20, 2006; 24(9): 1459 - 1473. [Abstract] [Full Text] [PDF]

				P. Maione, F. Perrone, C. Gallo, L. Manzione, F. Piantedosi, S. Barbera, S. Cigolari, F. Rosetti, E. Piazza, S. F. Robbiati, et al. Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non--Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study J. Clin. Oncol., October 1, 2005; 23(28): 6865 - 6872. [Abstract] [Full Text] [PDF]

				R. W Wilson, L. M Hutson, and D. VanStry Comparison of 2 Quality-of-Life Questionnaires in Women Treated for Breast Cancer: The RAND 36-Item Health Survey and the Functional Living Index-Cancer Physical Therapy, September 1, 2005; 85(9): 851 - 860. [Abstract] [Full Text] [PDF]

				Y.-B. Cheung, C. Goh, J. Thumboo, K.-S. Khoo, and J. Wee Variability and Sample Size Requirements of Quality-of-Life Measures: A Randomized Study of Three Major Questionnaires J. Clin. Oncol., August 1, 2005; 23(22): 4936 - 4944. [Abstract] [Full Text] [PDF]

				A. V. Rao, F. Hsieh, J. R. Feussner, and H. J. Cohen Geriatric Evaluation and Management Units in the Care of the Frail Elderly Cancer Patient J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(6): 798 - 803. [Abstract] [Full Text] [PDF]

				A R Giovagnoli, A Silvani, E Colombo, and A Boiardi Facets and determinants of quality of life in patients with recurrent high grade glioma J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 562 - 568. [Abstract] [Full Text] [PDF]

				G. Chang, E. J. Orav, T. K. McNamara, M.-Y. Tong, and J. H. Antin Psychosocial Function After Hematopoietic Stem Cell Transplantation Psychosomatics, February 1, 2005; 46(1): 34 - 40. [Abstract] [Full Text] [PDF]

				D. R. Buchanan, A. M. O'Mara, J. W. Kelaghan, and L. M. Minasian Quality-of-Life Assessment in the Symptom Management Trials of the National Cancer Institute-Supported Community Clinical Oncology Program J. Clin. Oncol., January 20, 2005; 23(3): 591 - 598. [Abstract] [Full Text] [PDF]

				G. Chang, E. J. Orav, M.-Y. Tong, and J. H. Antin Predictors of 1-Year Survival Assessed at the Time of Bone Marrow Transplantation Psychosomatics, October 1, 2004; 45(5): 378 - 385. [Abstract] [Full Text] [PDF]

				J. Mandelblatt, C. Armetta, K. R. Yabroff, W. Liang, and W. Lawrence Descriptive Review of the Literature on Breast Cancer Outcomes: 1990 Through 2000 J Natl Cancer Inst Monographs, October 1, 2004; 2004(33): 8 - 44. [Abstract] [Full Text] [PDF]

				E. Hanna, A. Sherman, D. Cash, D. Adams, E. Vural, C.-Y. Fan, and J. Y. Suen Quality of Life for Patients Following Total Laryngectomy vs Chemoradiation for Laryngeal Preservation Arch Otolaryngol Head Neck Surg, July 1, 2004; 130(7): 875 - 879. [Abstract] [Full Text] [PDF]

				J. C. Holland Psychological Care of Patients: Psycho-Oncology's Contribution J. Clin. Oncol., December 1, 2003; 21(90230): 253s - 265. [Abstract] [Full Text] [PDF]

				M. J. Fisch, M. L. Titzer, J. L. Kristeller, J. Shen, P. J. Loehrer, S.-H. Jung, S. D. Passik, and L. H. Einhorn Assessment of Quality of Life in Outpatients With Advanced Cancer: The Accuracy of Clinician Estimations and the Relevance of Spiritual Well-Being--A Hoosier Oncology Group Study J. Clin. Oncol., July 15, 2003; 21(14): 2754 - 2759. [Abstract] [Full Text] [PDF]

				F. Hoodin and S. Weber A Systematic Review of Psychosocial Factors Affecting Survival After Bone Marrow Transplantation Psychosomatics, June 1, 2003; 44(3): 181 - 195. [Abstract] [Full Text] [PDF]

				M. Nystedt, G. Berglund, C. Bolund, T. Fornander, and L. E. Rutqvist Side Effects of Adjuvant Endocrine Treatment in Premenopausal Breast Cancer Patients: A Prospective Randomized Study J. Clin. Oncol., May 1, 2003; 21(9): 1836 - 1844. [Abstract] [Full Text] [PDF]

				P. J. Goodwin, J. T. Black, L. J. Bordeleau, and P. A. Ganz Health-Related Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer--Taking Stock J Natl Cancer Inst, February 19, 2003; 95(4): 263 - 281. [Abstract] [Full Text] [PDF]

				M. A. Socinski, D. E. Morris, G. A. Masters, and R. Lilenbaum Chemotherapeutic Management of Stage IV Non-small Cell Lung Cancer Chest, January 1, 2003; 123(1_suppl): 226S - 243S. [Abstract] [Full Text] [PDF]

				M. N. Levine and P. A. Ganz Beyond the Development of Quality-of-Life Instruments: Where Do We Go From Here? J. Clin. Oncol., May 1, 2002; 20(9): 2215 - 2216. [Full Text] [PDF]

				J. C. Holland History of Psycho-Oncology: Overcoming Attitudinal and Conceptual Barriers Psychosom Med, March 1, 2002; 64(2): 206 - 221. [Abstract] [Full Text]

				C. I. Ireson, M. A. Ford, J. M. Hower, and R. W. Schwartz Outcome Report Cards: A Necessity in the Health Care Market Arch Surg, January 1, 2002; 137(1): 46 - 51. [Abstract] [Full Text] [PDF]

				G. Molenberghs and G. Verbeke A review on linear mixed models for longitudinal data, possibly subject to dropout Statistical Modeling, December 1, 2001; 1(4): 235 - 269. [Abstract] [PDF]

				J. A. Langendijk, N. K. Aaronson, J. M.A. de Jong, G. P.M. ten Velde, M. J. Muller, R. J. Lamers, B. J. Slotman, and E. F.M. Wouters Prospective Study on Quality of Life Before and After Radical Radiotherapy in Non-Small-Cell Lung Cancer J. Clin. Oncol., April 15, 2001; 19(8): 2123 - 2133. [Abstract] [Full Text] [PDF]

				B. Holzner, G. Kemmler, M. Kopp, R. Moschen, H. Schweigkofler, M. Dünser, R. Margreiter, W. W. Fleischhacker, and B. Sperner-Unterweger Quality of Life in Breast Cancer Patients--Not Enough Attention for Long-Term Survivors? Psychosomatics, April 1, 2001; 42(2): 117 - 123. [Abstract] [Full Text]

				K. Basen-Engquist, D. Bodurka-Bevers, M. A. Fitzgerald, K. Webster, D. Cella, S. Hu, and D. M. Gershenson Reliability and Validity of the Functional Assessment of Cancer Therapy-Ovarian J. Clin. Oncol., March 15, 2001; 19(6): 1809 - 1817. [Abstract] [Full Text] [PDF]

				C. R. Spiroch, D. Walsh, P. Mazanec, and K. A. Nelson Ask the patient: A semi-structured interview study of quality of life in advanced cancer American Journal of Hospice and Palliative Medicine, July 1, 2000; 17(4): 235 - 240. [Abstract] [PDF]

				A. C. Sherman, S. Simonton, D. C. Adams, E. Vural, B. Owens, and E. Hanna Assessing Quality of Life in Patients With Head and Neck Cancer: Cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck Module (QLQ-H&N35) Arch Otolaryngol Head Neck Surg, April 1, 2000; 126(4): 459 - 467. [Abstract] [Full Text] [PDF]

				D. Waldron, C. A. O'Boyle, M. Kearney, M. Moriarty, and D. Carney Quality-of-Life Measurement in Advanced Cancer: Assessing the Individual J. Clin. Oncol., November 1, 1999; 17(11): 3603 - 3611. [Abstract] [Full Text] [PDF]

				H. Heinzer, T. S. Mir, E. Huland, and H. Huland Subjective and Objective Prospective, Long-Term Analysis of Quality of Life During Inhaled Interleukin-2 Immunotherapy J. Clin. Oncol., November 1, 1999; 17(11): 3612 - 3620. [Abstract] [Full Text] [PDF]

				A. R Giovagnoli Quality of life in patients with stable disease after surgery, radiotherapy, and chemotherapy for malignant brain tumour J. Neurol. Neurosurg. Psychiatry, September 1, 1999; 67(3): 358 - 363. [Abstract] [Full Text]

				R. C. Bergan, E. Reed, C. E. Myers, D. Headlee, O. Brawley, H.-K. Cho, W. D. Figg, A. Tompkins, W. M. Linehan, D. Kohler, et al. A Phase II Study of High-Dose Tamoxifen in Patients with Hormone-refractory Prostate Cancer Clin. Cancer Res., September 1, 1999; 5(9): 2366 - 2373. [Abstract] [Full Text] [PDF]

				P. W. Kantoff, S. Halabi, M. Conaway, J. Picus, J. Kirshner, V. Hars, D. Trump, E. P. Winer, and N. J. Vogelzang Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study J. Clin. Oncol., August 1, 1999; 17(8): 2506 - 2506. [Abstract] [Full Text] [PDF]

				N Pratheepawanit, M S Salek, and I G Finlay The applicability of quality-of-life assessment in palliative care: comparing two quality-of-life measures Palliative Medicine, June 1, 1999; 13(4): 325 - 334. [Abstract] [PDF]

				M G Kenward and G Molenberghs Parametric models for incomplete continuous and categorical longitudinal data Statistical Methods in Medical Research, February 1, 1999; 8(1): 51 - 83. [Abstract] [PDF]

				P. E. Goss, E. P. Winer, I. F. Tannock, and L. H. Schwartz on behalf of the North American Vorozole Randomized Phase III Trial Comparing the New Potent and Selective Third-Generation Aromatase Inhibitor Vorozole With Megestrol Acetate in Postmenopausal Advanced Breast Cancer Patients J. Clin. Oncol., January 1, 1999; 17(1): 52 - 52. [Abstract] [Full Text] [PDF]

				C. C. Gotay and M. Wilson Use of Quality-of-Life Outcome Assessments in Current Cancer Clinical Trials Eval Health Prof, June 1, 1998; 21(2): 157 - 178. [Abstract] [PDF]

				B. Axelsson and P.-O. Sjoden Quality of life of cancer patients and their spouses in palliative home care Palliative Medicine, January 1, 1998; 12(1): 29 - 39. [Abstract] [PDF]

				S. Robin Cohen, B. M Mount, E. Bruera, M. Provost, J. Rowe, and K. Tong Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain Palliative Medicine, January 1, 1997; 11(1): 3 - 20. [Abstract] [PDF]

				S R. Cohen, B. M Mount, M. G Strobel, and F. Bui The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability Palliative Medicine, July 1, 1995; 9(3): 207 - 219. [Abstract] [PDF]

				I R McWhinney, M J Bass, and A Donner Evaluation of a palliative care service: problems and pitfalls BMJ, November 19, 1994; 309(6965): 1340 - 1342. [Abstract] [Full Text]

				D. MacAdam and M. Smith An initial assessment of suffering in terminal illness Palliative Medicine, January 1, 1987; 1(1): 37 - 47. [Abstract] [PDF]